The changes of clinical characteristics in 100 Japanese amyotrophic lateral sclerosis patients between 1980 and 2000

Clinical Neurology

Volumn 43, Issue 7, 2003, Pages 385-391

  Kimura, Fumiharu ^a   Shinoda, Keiichi ^b   Fujiwara, Shinya ^a   Fujimura, Chieko ^a   Nakajima, Hideto ^a   Furutama, Daisuke ^a   Sugino, Masakazu ^a   Hanafusa, Tosiaki ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

^b Hanwa Sumiyosi Hospital   (Japan)

Author keywords

ALSFRS R. ventilation support ratio; El Escoriol clinical criteria; Neurogenic muscle atrophy

Indexed keywords

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; ARTIFICIAL VENTILATION; BREATHING MUSCLE; CLINICAL FEATURE; DEATH; DISEASE COURSE; FEMALE; HUMAN; INCIDENCE; JAPAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; OUTCOMES RESEARCH; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL TIME; SYMPTOMATOLOGY;

AGED; AMYOTROPHIC LATERAL SCLEROSIS; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 0142087710     PISSN: 0009918X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Siddique T, Figlewicz DA, Pericak VM, et al: Linkage of a gene causing familial amyotrophic lateral sclerosis to chromosome 21 and evidence of genetic-locus heterogeneity. N Engl J Med 1991; 324: 1381-1384
2. Escarrabill J, Estopa R, Farrero E, et al: Long-term mechanical ventilation in amyotrophic lateral sclerosis. Respir Med 1998; 92: 438-441
3. Mazzini L, Corra T, Zaccala M, et al: Respiratory assistance with a non-invasive ventilator (Bipap) in MND/ALS patients: survival rates in a controlled trial. J Neurol Sci 1995; 129: 19-26
4. Mora G, Del-Piano M, Galante M, et al: Percutaneous endoscopic gastrostomy and enteral nutrition in amyotrophic lateral sclerosis. J Neurol 1995; 242: 695-698
5. Bensimon G, Lacomblez L, Meininger V: A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group. N Engl J Med 1994; 330: 585-591
6. Cedarbaum JM, Stambler N, Malta E, et al: The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci. 1999; 169: 13-21
7. Brooks BR: El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis, J Neurol Sci 1994; 124: 96-107
8. Yoshida S, Uebayashi Y, Kihira T, et al: Epidemiology of motor neuron disease in the Kii Peninsula of Japan, 1989-1993, active or disappearing focus. J Neurol Sci 1998; 155: 146-55
9. Seljeseth YM, Vollset SE, Tysnes OB: Increasing mortality from amyotrophic lateral sclerosis in Norway? Neurology 2000; 55: 1262-1266
10. Kondo K: Rising prevalence of neurodegenerative diseases worldwide. Intern Med 1996; 35: 238
11. Pongratz D: The diagnostic process in ALS. J Neurol Sci 1999; 165: S10-S13
12. ISIS Survey: an international study on the diagnostic process and its implications in amyotrophic lateral sclerosis. J Neurol Sci 1999; 246 Suppl 3: III1-III5
13. Swash M: Algorithm for ALS diagnosis and management. Neurology 1999; 53: S58-S62
14. Stambler N, Charatan M, Cedarbaum JM: Prognostic indicators of survival in ALS. ALS CNTF Treatment Study Group. Neurology 1998; 50: 66-72
15. Armon C, Moses D: Linear estimates of rates of disease progression as predictors of survival in patients with ALS entering clinical trials. J Neurol Sci 1998; 160 Suppl 1: S37-S41
16. Miller RG, Moore DH, Gelinas DF, et al: Phase III randomized trial of gabapentin in patients with amyotrophic lateral sclerosis. Neurology 2001; 56: 843-848
17. Jesse MC, Nancy S: Performance of the Amyotrophic Lateral sclerosis Functional Rating Scale (ALSFRS) in multicenter clinical trials. J Neurol Sci 1997; 152: S1-S9
18. Shields RK, Ruhland JL, Ross MA, et al: Analysis of health-related quality of life and muscle impairment in individuals with amyotrophic lateral sclerosis using the medical outcome survey and the Tufts Quantitative Neuromuscular Exam. Arch Phys Med Rehabil 1998; 79: 855-862
19. Desport JC, Preux PM, Truong TC, et al: Nutritional status is a prognostic factor for survival in ALS patients. Neurology 1999; 53: 1059-1063
20. Felice KJ: A longitudinal study comparing thenar motor unit number estimates to other quantitative tests in patients with amyotrophic lateral sclerosis. Muscle Nerve 1997; 20: 179-185
21. Chio A, Mora G, Leone M, et al: Early symptom progression rate is related to ALS outcome: a prospective population-based study. Neurology 2002; 59: 99-103